Different subtypes of EGFR exon19 mutation can affect prognosis of patients with non-small cell lung adenocarcinoma

AIMS: In this study, we determined whether different subtypes of epidermal growth factor receptor (EGFR) exon19 mutation are associated with the therapeutic effect of EGFR-tyrosine kinase inhibitors (TKIs) on advanced non-small cell lung adenocarcinoma. METHODS: A total of 122 patients with stage II...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yingying, Zhao, Jiuzhou, Ren, Pengfei, Wang, Bo, Zhao, Chengzhi, Shi, Chao, Wei, Bing, Ma, Jie, Guo, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211626/
https://www.ncbi.nlm.nih.gov/pubmed/30383772
http://dx.doi.org/10.1371/journal.pone.0201682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211626/
https://www.ncbi.nlm.nih.gov/pubmed/30383772
http://dx.doi.org/10.1371/journal.pone.0201682

Ejemplares similares